RecruitingNCT05621564

Pre-operative Therapy in Breast Cancer

The Effect of Pre-operative Therapy on Response and Survival in Breast Cancer


Sponsor

RenJi Hospital

Enrollment

6,032 participants

Start Date

Nov 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective and retrospective study to evaluate the effect of pre-operative therapy on response and survival, and compare the difference in response and survival by pre-operative regimen or by patient's clinicopathological characteristic in early or advanced breast cancer.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting detailed clinical, imaging, and biomarker data from women receiving pre-operative (neoadjuvant) therapy for breast cancer before their surgery, to better understand how different patients respond to treatment. **You may be eligible if...** - You are female and 18 years old or older - You have been diagnosed with primary breast cancer confirmed by biopsy - You are planning to receive pre-operative (neoadjuvant) therapy before your breast surgery - Your organ function is adequate **You may NOT be eligible if...** - You have a history of a significant neurological or psychiatric illness (including epilepsy or dementia) - Your doctor determines that participation is not appropriate for you Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGpre-operative therapy

pre-operative therapy includes pre-operative chemotherapy, radiation, endocrine therapy, target therapy and other anti-tumor therapy


Locations(1)

Renji Hospital, School of Medicine, Shanghai Jiaotong University

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05621564


Related Trials